Fulgent Genetics Cash on Hand 2015-2025 | FLGT
Fulgent Genetics cash on hand from 2015 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Fulgent Genetics Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $258 |
| 2023 | $424 |
| 2022 | $526 |
| 2021 | $450 |
| 2020 | $299 |
| 2019 | $28 |
| 2018 | $31 |
| 2017 | $26 |
| 2016 | $21 |
| 2015 | $0 |
| 2014 | $0 |
| Fulgent Genetics Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $320 |
| 2024-12-31 | $258 |
| 2024-09-30 | $213 |
| 2024-06-30 | $312 |
| 2024-03-31 | $306 |
| 2023-12-31 | $424 |
| 2023-09-30 | $468 |
| 2023-06-30 | $458 |
| 2023-03-31 | $504 |
| 2022-12-31 | $526 |
| 2022-09-30 | $571 |
| 2022-06-30 | $515 |
| 2022-03-31 | $585 |
| 2021-12-31 | $450 |
| 2021-09-30 | $470 |
| 2021-06-30 | $384 |
| 2021-03-31 | $410 |
| 2020-12-31 | $299 |
| 2020-09-30 | $75 |
| 2020-06-30 | $21 |
| 2020-03-31 | $27 |
| 2019-12-31 | $28 |
| 2019-09-30 | $32 |
| 2019-06-30 | $27 |
| 2019-03-31 | $29 |
| 2018-12-31 | $31 |
| 2018-09-30 | $33 |
| 2018-06-30 | $31 |
| 2018-03-31 | $28 |
| 2017-12-31 | $26 |
| 2017-09-30 | $26 |
| 2017-06-30 | $29 |
| 2017-03-31 | $27 |
| 2016-12-31 | $21 |
| 2016-09-30 | $8 |
| 2016-06-30 | $16 |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2014-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.582B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Doximity (DOCS) | United States | $11.561B | 53.52 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Omnicell (OMCL) | United States | $1.291B | 22.78 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |